![]() |
|||||||||||||||||
|
|
About Neuropcentiles:
Neuropcentiles is a software program that enables automated conversion of a patient's raw QST, NCS, and autonomic test results into specific percentile and normal deviate values, taking age and anthropometric characteristics into account. The operator enters the test used, test results, site tested, and physical variables such as age, gender, height, and weight. The software then calculates a meaningful percentile and normal deviate, placing the patient in the range of hypersensitivity to hyposensitivity based on a distribution of values in a normative population.
Population description: More than 300 healthy subjects from Rochester, MN, selected at random from lists of the Rochester population by gender and hemidecade between 18 and 74 years of age. Cohort was judged to be representative of a Caucasian population in northern U.S. cities. Please also see the further description of Neuropcentiles, below. Available in a variety of formats:
System requirements:
Neuropcentiles is a valuable tool for:
About the New, Enhanced Version 1.1:
Notes:
Further Description of Neuropcentiles
Neuropcentiles is a software program that enables automated conversion of a patient's raw QST, NCS, and autonomic test results into specific percentile and normal deviate values. For example, vibration threshold is recorded as a step of stimulus magnitude or as micrometers (µm) of vertical displacement. To be meaningful, one needs to know where this value occurs in the range of hypersensitivity to hyposensitivity. Because vibration sensation varies with age, sex, height, weight, and other anthropometric features, expressing results as a step function or as µm of displacement only is unsatisfactory. One needs to understand how the result relates to the distribution of values in a normative population. The procedure for estimating percentiles has been outlined by Peter C. O'Brien, PhD., and Peter J. Dyck, MD.1 More than 300 persons from Rochester, MN, excluding by examination patients with neurologic disease or diseases predisposing to neuropathy, were tested. Specific percentiles were then estimated for modality (such as vibration), site (such as great toe), age, and anthropometric characteristics.2 By entering the raw vibration detection threshold value and biographic and anthropometric characteristics into the Neuropcentiles program, the specific percentile value is calculated using the normal subject's data.1,2 This percentile is also given as a normal deviate, which relates percentiles to a normal distribution. For example, for the fiftieth percentile, the corresponding normal deviate is 0, since 50 percent of values in a normal distribution fall below 0. The normal deviate corresponding to the ninety-fifth percentile is 1.96, since 95 percent of values in a normal distribution fall below 1.96. Each attribute of nerve conduction entered into Neuropcentiles is similarly converted to a specific percentile and normal deviate value. There are major advantages to having nerve tests expressed as a percentile or as a normal deviate. The first is that it allows a direct, simple comparison of a test result to a normal distribution, which is a better estimate of abnormality than simply deciding whether a test result is normal or abnormal. The estimate takes more than age into account in expressing abnormality. To illustrate, for some attributes of nerve conduction height is as important a variable as age in determining the percentile position, whereas for other attributes weight or body mass index are important variables. The use of percentiles or normal deviate also permits comparison of the same person over time when age or anthropometric characteristics have changed. Use of normal deviates is very useful in epidemiologic studies and controlled clinical trials.3,4
1
O'Brien PC, Dyck PJ. Neurology 1995; 45: 17-23.
|
||||||||||||||||
| RETURN
TO TOP OF PAGE |
|||||||||||||||||
| WR Medical
Electronics Co. 123 North Second Street, Stillwater, MN 55082 USA. All content copyright 1998-2004 by WR Medical Electronics
Co. All rights reserved. For trademark and patent information, |
|||||||||||||||||